3/27
04:30 pm
anvs
Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE
High
Report
Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE
3/25
08:08 am
anvs
Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program [Yahoo! Finance]
Medium
Report
Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program [Yahoo! Finance]
3/25
08:00 am
anvs
Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program
Medium
Report
Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program
3/21
05:05 pm
anvs
Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Medium
Report
Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
3/11
09:14 am
anvs
Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment [Yahoo! Finance]
Low
Report
Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment [Yahoo! Finance]
3/11
08:00 am
anvs
Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment
Medium
Report
Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment
2/24
05:17 am
anvs
Annovis to Host Patients' Live Forum on February 27, 2025 [Yahoo! Finance]
Medium
Report
Annovis to Host Patients' Live Forum on February 27, 2025 [Yahoo! Finance]
2/19
08:30 am
anvs
Annovis to Host Patients’ Live Forum on February 27, 2025
Medium
Report
Annovis to Host Patients’ Live Forum on February 27, 2025
2/13
01:37 pm
anvs
Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight [Yahoo! Finance]
Low
Report
Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight [Yahoo! Finance]
2/10
08:00 am
anvs
Annovis Bio, Inc. (NYSE: ANVS) had its "hold" rating re-affirmed by analysts at D. Boral Capital.
High
Report
Annovis Bio, Inc. (NYSE: ANVS) had its "hold" rating re-affirmed by analysts at D. Boral Capital.
2/8
04:47 am
anvs
Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024 [Yahoo! Finance]
Medium
Report
Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024 [Yahoo! Finance]
2/8
04:47 am
anvs
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference [Yahoo! Finance]
Medium
Report
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference [Yahoo! Finance]
2/8
04:47 am
anvs
Annovis begins treatment of subjects in Alzheimer's trial [Yahoo! Finance]
Medium
Report
Annovis begins treatment of subjects in Alzheimer's trial [Yahoo! Finance]
2/8
04:47 am
anvs
Annovis Bio Reports Second Quarter Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Annovis Bio Reports Second Quarter Financial Results and Provides Business Update [Yahoo! Finance]
2/8
04:47 am
anvs
Annovis Invited to Present at National Institute on Aging Workshop on Dementia with Lewy Bodies (DLB) [Yahoo! Finance]
Medium
Report
Annovis Invited to Present at National Institute on Aging Workshop on Dementia with Lewy Bodies (DLB) [Yahoo! Finance]
2/8
04:47 am
anvs
Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer's Disease [Yahoo! Finance]
Medium
Report
Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer's Disease [Yahoo! Finance]
2/8
04:47 am
anvs
FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer's Studies, Paving the Way to NDAs [Yahoo! Finance]
Medium
Report
FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer's Studies, Paving the Way to NDAs [Yahoo! Finance]
2/8
04:47 am
anvs
Annovis Bio Reports Third Quarter Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Annovis Bio Reports Third Quarter Financial Results and Provides Business Update [Yahoo! Finance]
2/8
04:47 am
anvs
Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations [Yahoo! Finance]
Medium
Report
Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations [Yahoo! Finance]
2/8
04:47 am
anvs
Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist [Yahoo! Finance]
Medium
Report
Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist [Yahoo! Finance]
2/8
04:47 am
anvs
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis Bio [Yahoo! Finance]
Medium
Report
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis Bio [Yahoo! Finance]
2/8
04:47 am
anvs
Annovis Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra [Yahoo! Finance]
Medium
Report
Annovis Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra [Yahoo! Finance]
2/7
09:35 am
anvs
Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Low
Report
Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
2/7
08:00 am
anvs
Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
Medium
Report
Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
2/5
08:00 am
anvs
Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer’s Disease
Low
Report
Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer’s Disease